What are the risks of self-administering compounded semaglutide
To qualify for semaglutide weight loss treatments, adults usually need to meet specific requirements: Health professionals check your medical history and current health before starting semaglutide
However, when combined with insulin or sulfonylureas, the risk of hypoglycemia increases substantially, potentially affecting twenty to thirty percent of patients if doses of concurrent medications are not appropriately adjusted
Ozempic , while primarily prescribed for managing type 2 diabetes, has demonstrated significant potential for promoting weight loss, even in individuals without diabetes
Supplementary material The Supplementary Material for this article can be found online at: Abbreviations GLP-1RA:glucagon-like peptide-1 receptor agonist,FDA:the adverse event reporting system of the U.S